Cargando…
Deciphering the Link Between Hyperhomocysteinemia and Ceramide Metabolism in Alzheimer-Type Neurodegeneration
Aging is one of the strongest risk factor for Alzheimer's disease (AD). However, several data suggest that dyslipidemia can either contribute or serve as co-factors in AD appearance. AD could be examined as a metabolic disorder mediated by peripheral insulin resistance. Insulin resistance is as...
Autores principales: | Le Stunff, Hervé, Véret, Julien, Kassis, Nadim, Denom, Jessica, Meneyrol, Kelly, Paul, Jean-Louis, Cruciani-Guglielmacci, Céline, Magnan, Christophe, Janel, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684947/ https://www.ncbi.nlm.nih.gov/pubmed/31417486 http://dx.doi.org/10.3389/fneur.2019.00807 |
Ejemplares similares
-
Homocysteine Metabolism Pathway Is Involved in the Control of Glucose Homeostasis: A Cystathionine Beta Synthase Deficiency Study in Mouse
por: Cruciani-Guglielmacci, Céline, et al.
Publicado: (2022) -
Brain Ceramide Metabolism in the Control of Energy Balance
por: Cruciani-Guglielmacci, Céline, et al.
Publicado: (2017) -
Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker rats
por: Campana, Mélanie, et al.
Publicado: (2017) -
Homocysteine-lowering gene therapy rescues signaling pathways in brain of mice with intermediate hyperhomocysteinemia
por: Baloula, Vanessa, et al.
Publicado: (2018) -
Role of hypothalamic de novo ceramides synthesis in obesity and associated metabolic disorders
por: Magnan, Christophe, et al.
Publicado: (2021)